Status: current, Defined. Date: 31-Aug 2012. Module: Australian Medicines Terminology module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 2959821000168116 | Mitozantrone (Novotech) (mitozantrone 25 mg / 12.5 mL) injection, 12.5 mL vial (trade product unit of use) | en | Fully specified name | Active | Case sensitive | Australian Medicines Terminology module |
| 2959831000168118 | Mitozantrone (Novotech) 25 mg/12.5 mL injection, 12.5 mL vial | en | Synonym | Active | Case sensitive | Australian Medicines Terminology module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Mitozantrone (Novotech) (mitozantrone 25 mg / 12.5 mL) injection, 12.5 mL vial (trade product unit of use) | has manufactured dose form | injection | true | Inferred relationship | Some | ||
| Mitozantrone (Novotech) (mitozantrone 25 mg / 12.5 mL) injection, 12.5 mL vial (trade product unit of use) | Is a | trade product unit of use | true | Inferred relationship | Some | ||
| Mitozantrone (Novotech) (mitozantrone 25 mg / 12.5 mL) injection, 12.5 mL vial (trade product unit of use) | Is a | Mitozantrone (Novotech) | true | Inferred relationship | Some | ||
| Mitozantrone (Novotech) (mitozantrone 25 mg / 12.5 mL) injection, 12.5 mL vial (trade product unit of use) | Is a | mitozantrone 25 mg/12.5 mL injection, vial | true | Inferred relationship | Some | ||
| Mitozantrone (Novotech) (mitozantrone 25 mg / 12.5 mL) injection, 12.5 mL vial (trade product unit of use) | has manufactured dose form | concentrated injection | false | Inferred relationship | Some | ||
| Mitozantrone (Novotech) (mitozantrone 25 mg / 12.5 mL) injection, 12.5 mL vial (trade product unit of use) | has intended active ingredient | mitozantrone | true | Inferred relationship | Some | 255934348 | |
| Mitozantrone (Novotech) (mitozantrone 25 mg / 12.5 mL) injection, 12.5 mL vial (trade product unit of use) | has Australian BoSS | mitozantrone | true | Inferred relationship | Some | 255934348 | |
| Mitozantrone (Novotech) (mitozantrone 25 mg / 12.5 mL) injection, 12.5 mL vial (trade product unit of use) | has unit of use | vial | true | Inferred relationship | Some | 255934349 |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Mitozantrone (Novotech) 25 mg/12.5 mL injection, 12.5 mL vial | has TPUU | True | Mitozantrone (Novotech) (mitozantrone 25 mg / 12.5 mL) injection, 12.5 mL vial (trade product unit of use) | Inferred relationship | Some | 1 |
| Mitozantrone (Novotech) 25 mg/12.5 mL injection, 12.5 mL vial | has TPUU | True | Mitozantrone (Novotech) (mitozantrone 25 mg / 12.5 mL) injection, 12.5 mL vial (trade product unit of use) | Inferred relationship | Some | 1 |
Reference Sets
Trade product unit of use reference set
FHIR